IRLCF yields 0.83% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, IRLCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IRLCF + JNJ for your $10,000?
Israel Corporation Ltd, through its investee companies, operates in the specialty minerals and refining businesses in Asia, Europe, South America, North America, and internationally. The company offers bromine and bromine-based compounds; salts, magnesium chloride, magnesia-based products, phosphorus-based flame retardants, and functional fluids; potash and electricity; phosphate-based specialty products; and controlled release fertilizers, water soluble fertilizers, liquid fertilizers and straights, FertilizerspluS range products, soil and foliar micronutrients, secondary nutrients, biostimulants, soil conditioners, seed treatment products, and adjuvants. It also produces fuel products; raw materials for the petrochemical industry; and materials for the plastics industry, as well as provides power and water services to various industries in Haifa. The company is based in Tel Aviv, Israel.
Full IRLCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.